2026-2030年全球3D心臟定位系統市場
市場調查報告書
商品編碼
2126025

2026-2030年全球3D心臟定位系統市場

Global 3D Cardiac Mapping Systems Market 2026-2030

出版日期: | 出版商: TechNavio | 英文 302 Pages | 訂單完成後即時交付

價格
簡介目錄

全球 3D心臟定位系統市場預計將從 2025 年到 2030 年成長至 5.391 億美元,預測期內複合年成長率為 8.7%。

本報告對全球 3D心臟定位系統市場進行了全面分析,包括市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括心血管疾病 (CVD) 盛行率的上升、測繪精度技術的快速進步以及人們對微創手術日益成長的偏好。

本研究客觀地結合了一手和二手訊息,包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

市場範圍
基準年 2025
年末 2030
調查期 2026-2030
成長勢頭 加速度
2026 年同比比較 8.2%
複合年成長率 8.7%
增量 5.391億美元

本研究指出,人工智慧和自動化數據處理的整合是未來幾年全球3D心臟定位系統市場成長的關鍵促進因素之一。此外,脈衝電場消融和整合導航系統的日益普及,以及弱視手術中心(ASC)和分散式醫療模式的興起,預計將帶來顯著的市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

  • 分析價格敏感度、生命週期、顧客購買籃子、採用率和購買標準。
  • 輸入的重要性及差異化因素
  • 干擾因素
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場的定義
  • 市場區隔分析
  • 2025年市場規模
  • 市場展望,2025-2030年

第5章 市場規模與表現

  • 2020-2024年全球3D心臟定位系統市場
  • 產品細分市場分析,2020-2024 年
  • 2020-2024年基於技術的細分市場分析
  • 基於應用領域的細分市場分析,2020-2024 年
  • 區域區隔市場分析,2020-2024 年
  • 2020-2024年各國細分市場分析

第6章 定性分析

  • 人工智慧的影響:全球3D心臟定位系統市場
  • 地緣政治衝突的影響:全球3D心臟定位系統市場

第7章:五力分析

第8章 市場區隔:依產品

  • 比較:按產品
  • 接觸式3D心臟定位系統
  • 非接觸式3D心臟定位系統
  • 市場機會:依產品分類

第9章 市場區隔:依技術分類

  • 比較:按技術
  • EAM
  • 磁電阻系統
  • 人工智慧整合系統
  • 市場機會:依技術分類

第10章 市場區隔:依應用

  • 比較:透過應用
  • AF
  • VT
  • SVT
  • 市場機會:依應用領域分類

第11章 客戶情況

第12章 區域情勢

  • 區域細分
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
  • 世界其他地區(RoW)
    • 巴西
    • 沙烏地阿拉伯
    • UAE
    • 土耳其
    • 阿根廷
    • 哥倫比亞
    • 南非
    • 以色列
  • 市場機會:按地區分類

第13章 促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第14章 競爭格局

  • 概述
  • 競爭格局
  • 混亂局面
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 公司排名指標
  • 企業市場定位
  • Abbott Laboratories
  • APT Medical Inc.
  • Becton Dickinson and Co.
  • BIOTRONIK SE and Co. KG
  • Boston Scientific Corp.
  • GE HealthCare Technologies
  • Johnson and Johnson
  • Kardium Inc.
  • Koninklijke Philips NV
  • Lepu Medical Co. Ltd.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Nihon Kohden Corp.
  • Siemens Healthineers AG
  • Vektor Medical Inc.

第16章附錄

簡介目錄
Product Code: IRTNTR72855

The global 3d cardiac mapping systems market is forecasted to grow by USD 539.1 mn during 2025-2030, accelerating at a CAGR of 8.7% during the forecast period. The report on the global 3d cardiac mapping systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating prevalence of cvd, rapid technological advancements in mapping accuracy, growing preference for minimally invasive procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 20268.2%
CAGR8.7%
Incremental Value$539.1 mn

Technavio's global 3d cardiac mapping systems market is segmented as below:

By Product

  • Contact 3D cardiac mapping systems
  • Non-contact 3D cardiac mapping systems

By Technology

  • EAM
  • Magnetic and impedance-based systems
  • AI-integrated systems

By Application

  • AF
  • VT
  • SVT

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
  • Asia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the integration of ai and automated data processing as one of the prime reasons driving the global 3d cardiac mapping systems market growth during the next few years. Also, expansion of pulsed field ablation and integrated navigation systems and shift toward ascs and decentralized care models will lead to sizable demand in the market.

The report on the global 3d cardiac mapping systems market covers the following areas:

  • Global 3d cardiac mapping systems market sizing
  • Global 3d cardiac mapping systems market forecast
  • Global 3d cardiac mapping systems market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global 3d cardiac mapping systems market vendors that include Abbott Laboratories, APN Health LLC, APT Medical Inc., Becton Dickinson and Co., BIOTRONIK SE and Co. KG, Boston Scientific Corp., CoreMap Inc., Corify Care SL, EnChannel Medical Ltd., EP Solutions SA, GE HealthCare Technologies, Johnson and Johnson, Kardium Inc., Koninklijke Philips NV, Lepu Medical Co. Ltd., Medtronic Plc, MicroPort Scientific Corp., Nihon Kohden Corp., Siemens Healthineers AG, Vektor Medical Inc., Volta Medical. Also, the global 3d cardiac mapping systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Technology
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global 3D Cardiac Mapping Systems Market 2020 - 2024
    • Historic Market Size - Data Table on Global 3D Cardiac Mapping Systems Market 2020 - 2024 ($ million)
  • 5.2 Product segment analysis 2020 - 2024
    • Historic Market Size - Product Segment 2020 - 2024 ($ million)
  • 5.3 Technology segment analysis 2020 - 2024
    • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
  • 5.4 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on global 3D cardiac mapping systems market
  • 6.2 Impact of geopolitical conflicts on global 3D cardiac mapping systems market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Product

  • 8.1 Market segments
  • 8.2 Comparison by Product
  • 8.3 Contact 3D cardiac mapping systems - Market size and forecast 2025-2030
  • 8.4 Non-contact 3D cardiac mapping systems - Market size and forecast 2025-2030
  • 8.5 Market opportunity by Product
    • Market opportunity by Product ($ million)

9 Market Segmentation by Technology

  • 9.1 Market segments
  • 9.2 Comparison by Technology
  • 9.3 EAM - Market size and forecast 2025-2030
  • 9.4 Magnetic and impedance-based systems - Market size and forecast 2025-2030
  • 9.5 AI-integrated systems - Market size and forecast 2025-2030
  • 9.6 Market opportunity by Technology
    • Market opportunity by Technology ($ million)

10 Market Segmentation by Application

  • 10.1 Market segments
  • 10.2 Comparison by Application
  • 10.3 AF - Market size and forecast 2025-2030
  • 10.4 VT - Market size and forecast 2025-2030
  • 10.5 SVT - Market size and forecast 2025-2030
  • 10.6 Market opportunity by Application
    • Market opportunity by Application ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 Spain - Market size and forecast 2025-2030
    • 12.4.6 The Netherlands - Market size and forecast 2025-2030
  • 12.5 Asia - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 India - Market size and forecast 2025-2030
    • 12.5.3 Japan - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Indonesia - Market size and forecast 2025-2030
    • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 UAE - Market size and forecast 2025-2030
    • 12.6.4 Turkey - Market size and forecast 2025-2030
    • 12.6.5 Argentina - Market size and forecast 2025-2030
    • 12.6.6 Colombia - Market size and forecast 2025-2030
    • 12.6.7 South Africa - Market size and forecast 2025-2030
    • 12.6.8 Israel - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Escalating prevalence of CVD
    • Rapid technological advancements in mapping accuracy
    • Growing preference for minimally invasive procedures
  • 13.2 Market challenges
    • Prohibitive capital expenditure and equipment costs
    • Shortage of skilled electrophysiologists and technical expertise
    • Complex regulatory approvals and stringent reimbursement frameworks
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Integration of AI and automated data processing
    • Expansion of pulsed field ablation and integrated navigation systems
    • Shift toward ASCs and decentralized care models

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 15.5 APT Medical Inc.
    • APT Medical Inc. - Overview
    • APT Medical Inc. - Product / Service
    • APT Medical Inc. - Key offerings
    • SWOT
  • 15.6 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 15.7 BIOTRONIK SE and Co. KG
    • BIOTRONIK SE and Co. KG - Overview
    • BIOTRONIK SE and Co. KG - Product / Service
    • BIOTRONIK SE and Co. KG - Key offerings
    • SWOT
  • 15.8 Boston Scientific Corp.
    • Boston Scientific Corp. - Overview
    • Boston Scientific Corp. - Business segments
    • Boston Scientific Corp. - Key offerings
    • Boston Scientific Corp. - Segment focus
    • SWOT
  • 15.9 GE HealthCare Technologies
    • GE HealthCare Technologies - Overview
    • GE HealthCare Technologies - Business segments
    • GE HealthCare Technologies - Key news
    • GE HealthCare Technologies - Key offerings
    • GE HealthCare Technologies - Segment focus
    • SWOT
  • 15.10 Johnson and Johnson
    • Johnson and Johnson - Overview
    • Johnson and Johnson - Business segments
    • Johnson and Johnson - Key news
    • Johnson and Johnson - Key offerings
    • Johnson and Johnson - Segment focus
    • SWOT
  • 15.11 Kardium Inc.
    • Kardium Inc. - Overview
    • Kardium Inc. - Product / Service
    • Kardium Inc. - Key offerings
    • SWOT
  • 15.12 Koninklijke Philips NV
    • Koninklijke Philips NV - Overview
    • Koninklijke Philips NV - Business segments
    • Koninklijke Philips NV - Key news
    • Koninklijke Philips NV - Key offerings
    • Koninklijke Philips NV - Segment focus
    • SWOT
  • 15.13 Lepu Medical Co. Ltd.
    • Lepu Medical Co. Ltd. - Overview
    • Lepu Medical Co. Ltd. - Product / Service
    • Lepu Medical Co. Ltd. - Key offerings
    • SWOT
  • 15.14 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
    • SWOT
  • 15.15 MicroPort Scientific Corp.
    • MicroPort Scientific Corp. - Overview
    • MicroPort Scientific Corp. - Business segments
    • MicroPort Scientific Corp. - Key offerings
    • MicroPort Scientific Corp. - Segment focus
    • SWOT
  • 15.16 Nihon Kohden Corp.
    • Nihon Kohden Corp. - Overview
    • Nihon Kohden Corp. - Business segments
    • Nihon Kohden Corp. - Key offerings
    • Nihon Kohden Corp. - Segment focus
    • SWOT
  • 15.17 Siemens Healthineers AG
    • Siemens Healthineers AG - Overview
    • Siemens Healthineers AG - Business segments
    • Siemens Healthineers AG - Key offerings
    • Siemens Healthineers AG - Segment focus
    • SWOT
  • 15.18 Vektor Medical Inc.
    • Vektor Medical Inc. - Overview
    • Vektor Medical Inc. - Product / Service
    • Vektor Medical Inc. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations